GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
GSK Adds Drug to Contract Pharmacy Restriction List
Views
GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.